Physician profile
Hamid Bashir
NPI 1225257694
$8,640.67
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,012 · 2020: $2,398 · 2021: $339 · 2022: $1,039 · 2023: $853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $6,827.26 | 2019-2023 | |
| Abbvie INC. | $408.94 | 2020-2023 | Skyrizi, Rinvoq |
| Novartis Pharmaceuticals Corporation | $349.18 | 2022-2023 | |
| Amgen INC. | $321.07 | 2021-2023 | Tavneos, Enbrel, Otezla |
| Ucb, INC. | $248.54 | 2021-2023 | Cimzia |
| Lilly USA, LLC | $131.19 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.40 | 2022-2023 | Cyltezo |
| Astrazeneca Pharmaceuticals Lp | $81.58 | 2021-2023 | Evusheld |
| Genzyme Corporation | $59.36 | 2023 | |
| Glaxosmithkline, LLC. | $45.17 | 2019-2022 | |
| Sandoz INC. | $32.70 | 2023 | Hyrimoz |
| Horizon Therapeutics Plc | $31.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamid Bashir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.